FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants Warning Letters Issued to Two Companies for Illegally Selling Probiotic Products to Treat Diseases in Preterm Infants

https://www.fda.gov/news-events/press-announcements/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants?utm_medium=email&utm_source=govdelivery